Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trial

Introduction Current international guidelines recommend ECG monitoring after an ischaemic stroke to detect atrial fibrillation (AF) in order to prevent stroke recurrence. However, optimal strategies to detect AF and the downstream management to prevent stroke recurrence remain to be established. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Tan, Yan Liang, Yong Liu, Wei Jiang, Duo Huang, Ning Tan, Chung-Wah Siu, Jo Jo Hai, Xiaoyu Huang, Jianfeng Ye, Ji-yan Chen, Chun Ka Wong, Mi Zhou, Li-Xue Yin, Ming-Liang Zuo, Kui Kai Lau, Zhen Lei, Yingqing Feng, Bryan P Yan, Wen-Sheng Yue, Wen-Jun Zhang, Yuk-Ming Lau, Hin-Wai LUI, Koon-Ho Chan, Toi Meng Mok, Weng-Chio Tam, Kun-Chong Tam, Xiuhua Feng, Xiaofei Jiang, Guanming Tan, Mario Alberto Evora
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/7/e053466.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575856057253888
author Jing Tan
Yan Liang
Yong Liu
Wei Jiang
Duo Huang
Ning Tan
Chung-Wah Siu
Jo Jo Hai
Xiaoyu Huang
Jianfeng Ye
Ji-yan Chen
Chun Ka Wong
Mi Zhou
Li-Xue Yin
Ming-Liang Zuo
Kui Kai Lau
Zhen Lei
Yingqing Feng
Bryan P Yan
Wen-Sheng Yue
Wen-Jun Zhang
Yuk-Ming Lau
Hin-Wai LUI
Koon-Ho Chan
Toi Meng Mok
Weng-Chio Tam
Kun-Chong Tam
Xiuhua Feng
Xiaofei Jiang
Guanming Tan
Mario Alberto Evora
author_facet Jing Tan
Yan Liang
Yong Liu
Wei Jiang
Duo Huang
Ning Tan
Chung-Wah Siu
Jo Jo Hai
Xiaoyu Huang
Jianfeng Ye
Ji-yan Chen
Chun Ka Wong
Mi Zhou
Li-Xue Yin
Ming-Liang Zuo
Kui Kai Lau
Zhen Lei
Yingqing Feng
Bryan P Yan
Wen-Sheng Yue
Wen-Jun Zhang
Yuk-Ming Lau
Hin-Wai LUI
Koon-Ho Chan
Toi Meng Mok
Weng-Chio Tam
Kun-Chong Tam
Xiuhua Feng
Xiaofei Jiang
Guanming Tan
Mario Alberto Evora
author_sort Jing Tan
collection DOAJ
description Introduction Current international guidelines recommend ECG monitoring after an ischaemic stroke to detect atrial fibrillation (AF) in order to prevent stroke recurrence. However, optimal strategies to detect AF and the downstream management to prevent stroke recurrence remain to be established. The objective of the study was to explore the use of long-term home-based ECG monitoring for AF detection and stroke prevention in patients with a history of stroke.Methods and analysis This prospective, randomised, open-label trial with blinded endpoint adjudication aimed to evaluate the efficacy of long-term home-based ECG monitoring for AF detection and stroke prevention in a 24-month period. Patients aged >18 years with a history of ischaemic stroke will be stratified according to the time from the index ischaemic stroke: <1, 1–3 and >3 years and then randomised in 1:1 to (1) home-based AF screening and (2) control. The home-based AF screening system comprises (1) a handheld single-lead ECG recorder (Comfit Healthcare Devices, Hong Kong SAR, China) and (2) a patient-facing smartphone application specially designed for the study. Patients randomised to the home-based AF group will record a 30 s single-lead ECG using a specially designed handheld ECG device every morning or when symptomatic. All remotely obtained data will be automatically transmitted in real-time through the study smartphone application to a secured cloud hosting and analysed using an artificial intelligence-based diagnostic system. When a diagnosis of AF is made with the system, the patients will be called back for a formal cardiology consultation within 1 week. The primary endpoint is the time to first detection of AF at 24 months of follow-up. Secondary endpoints include recurrent stroke or transient ischaemic attack, initiation of long-term anticoagulation therapy, hospitalisation for heart failure, cardiovascular death and all-cause death.Ethics and dissemination The study protocol has been approved by the institutional review board of The University of Hong Kong, and Hong Kong West Cluster, Hospital Authority, Hong Kong SAR, China. Results will be published in peer-reviewed journals.Trial registration number NCT04523649.
format Article
id doaj-art-56795e3afbb245cd95d5c452143ec20a
institution Kabale University
issn 2044-6055
language English
publishDate 2022-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-56795e3afbb245cd95d5c452143ec20a2025-01-31T16:55:09ZengBMJ Publishing GroupBMJ Open2044-60552022-07-0112710.1136/bmjopen-2021-053466Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trialJing Tan0Yan Liang1Yong Liu2Wei Jiang3Duo Huang4Ning Tan5Chung-Wah Siu6Jo Jo Hai7Xiaoyu Huang8Jianfeng Ye9Ji-yan Chen10Chun Ka Wong11Mi Zhou12Li-Xue Yin13Ming-Liang Zuo14Kui Kai Lau15Zhen Lei16Yingqing Feng17Bryan P Yan18Wen-Sheng Yue19Wen-Jun Zhang20Yuk-Ming Lau21Hin-Wai LUI22Koon-Ho Chan23Toi Meng Mok24Weng-Chio Tam25Kun-Chong Tam26Xiuhua Feng27Xiaofei Jiang28Guanming Tan29Mario Alberto Evora3028 State Key Laboratory of Oncology, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaFudan University School of Nursing, Shanghai, Shanghai, China2 Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, ChinaDepartment of Cardiology, Union Shenzhen Hospital, Huazhong University of Science and Technology, Shenzhen, ChinaCardiology Division, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaDepartment of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, Guangdong, ChinaCardiology Division, Department of Medicine, University of Hong Kong, Hong Kong, Hong KongCardiology Division, Department of Medicine, University of Hong Kong, Hong Kong, Hong KongDepartment of Cardiology, People`s Hospital of Yangjiang, Yangjiang, Guangdong, ChinaDepartment of Cardiology, Dongguan TCM Hospital, Dongguan, ChinaDepartment of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, Guangdong, ChinaCardiology Division, Department of Medicine, University of Hong Kong, Hong Kong, Hong KongCardiology Division, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaDepartment of Echocardiography & Non-invasive Cardiology Laboratory, Sichuan Academy of Medical Sciences and Sichuan People`s Hospital, Chengdu, Sichuan, ChinaDepartment of Echocardiography & Non-invasive Cardiology Laboratory, Sichuan Academy of Medical Sciences and Sichuan People`s Hospital, Chengdu, Sichuan, ChinaNeurology Division, Department of Medicine, University of Hong Kong, Hong Kong, Hong KongDepartment of Cardiology, Union Shenzhen Hospital, Huazhong University of Science and Technology, Shenzhen, ChinaDepartment of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, Guangdong, ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong KongMedical Imaging Key Laboratory, Affiliated Hospital of North Sichuan Medical College, Sichuan, ChinaDepartment of Ultrasound in Medicine, Sichuan Provincial People’s Hospital Affiliated Wenjiang Hospital, Chengdu, ChinaCardiology Division, Department of Medicine, University of Hong Kong, Hong Kong, Hong KongCardiology Division, Department of Medicine, University of Hong Kong, Hong Kong, Hong KongNeurology Division, Department of Medicine, University of Hong Kong, Hong Kong, Hong KongDepartment of Medicine, Centro Hospitalar Conde de São Januário, Macau, Macau, ChinaDepartment of Medicine, Centro Hospitalar Conde de São Januário, Macau, Macau, ChinaDepartment of Cardiology, Kiang Wu Hospital, Macau, Macau, ChinaDepartment of Cardiology, Kiang Wu Hospital, Macau, Macau, ChinaDepartment of Cardiology, Zhuhai People’s Hospital, Zhuhai, ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong KongDepartment of Medicine, Centro Hospitalar Conde de São Januário, Macau, Macau, ChinaIntroduction Current international guidelines recommend ECG monitoring after an ischaemic stroke to detect atrial fibrillation (AF) in order to prevent stroke recurrence. However, optimal strategies to detect AF and the downstream management to prevent stroke recurrence remain to be established. The objective of the study was to explore the use of long-term home-based ECG monitoring for AF detection and stroke prevention in patients with a history of stroke.Methods and analysis This prospective, randomised, open-label trial with blinded endpoint adjudication aimed to evaluate the efficacy of long-term home-based ECG monitoring for AF detection and stroke prevention in a 24-month period. Patients aged >18 years with a history of ischaemic stroke will be stratified according to the time from the index ischaemic stroke: <1, 1–3 and >3 years and then randomised in 1:1 to (1) home-based AF screening and (2) control. The home-based AF screening system comprises (1) a handheld single-lead ECG recorder (Comfit Healthcare Devices, Hong Kong SAR, China) and (2) a patient-facing smartphone application specially designed for the study. Patients randomised to the home-based AF group will record a 30 s single-lead ECG using a specially designed handheld ECG device every morning or when symptomatic. All remotely obtained data will be automatically transmitted in real-time through the study smartphone application to a secured cloud hosting and analysed using an artificial intelligence-based diagnostic system. When a diagnosis of AF is made with the system, the patients will be called back for a formal cardiology consultation within 1 week. The primary endpoint is the time to first detection of AF at 24 months of follow-up. Secondary endpoints include recurrent stroke or transient ischaemic attack, initiation of long-term anticoagulation therapy, hospitalisation for heart failure, cardiovascular death and all-cause death.Ethics and dissemination The study protocol has been approved by the institutional review board of The University of Hong Kong, and Hong Kong West Cluster, Hospital Authority, Hong Kong SAR, China. Results will be published in peer-reviewed journals.Trial registration number NCT04523649.https://bmjopen.bmj.com/content/12/7/e053466.full
spellingShingle Jing Tan
Yan Liang
Yong Liu
Wei Jiang
Duo Huang
Ning Tan
Chung-Wah Siu
Jo Jo Hai
Xiaoyu Huang
Jianfeng Ye
Ji-yan Chen
Chun Ka Wong
Mi Zhou
Li-Xue Yin
Ming-Liang Zuo
Kui Kai Lau
Zhen Lei
Yingqing Feng
Bryan P Yan
Wen-Sheng Yue
Wen-Jun Zhang
Yuk-Ming Lau
Hin-Wai LUI
Koon-Ho Chan
Toi Meng Mok
Weng-Chio Tam
Kun-Chong Tam
Xiuhua Feng
Xiaofei Jiang
Guanming Tan
Mario Alberto Evora
Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trial
BMJ Open
title Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trial
title_full Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trial
title_fullStr Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trial
title_full_unstemmed Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trial
title_short Protocol for Home-Based Solution for Remote Atrial Fibrillation Screening to Prevent Recurrence Stroke (HUA-TUO AF Trial): a randomised controlled trial
title_sort protocol for home based solution for remote atrial fibrillation screening to prevent recurrence stroke hua tuo af trial a randomised controlled trial
url https://bmjopen.bmj.com/content/12/7/e053466.full
work_keys_str_mv AT jingtan protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT yanliang protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT yongliu protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT weijiang protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT duohuang protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT ningtan protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT chungwahsiu protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT jojohai protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT xiaoyuhuang protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT jianfengye protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT jiyanchen protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT chunkawong protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT mizhou protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT lixueyin protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT mingliangzuo protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT kuikailau protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT zhenlei protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT yingqingfeng protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT bryanpyan protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT wenshengyue protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT wenjunzhang protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT yukminglau protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT hinwailui protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT koonhochan protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT toimengmok protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT wengchiotam protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT kunchongtam protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT xiuhuafeng protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT xiaofeijiang protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT guanmingtan protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial
AT marioalbertoevora protocolforhomebasedsolutionforremoteatrialfibrillationscreeningtopreventrecurrencestrokehuatuoaftrialarandomisedcontrolledtrial